Key statistics
As of last trade SAGE Therapeutics Inc (SG7:BER) traded at 6.03, 4.43% above its 52-week low of 5.78, set on Oct 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.05 |
---|---|
High | 6.05 |
Low | 6.03 |
Bid | 5.85 |
Offer | 6.21 |
Previous close | 5.97 |
Average volume | 112.50 |
---|---|
Shares outstanding | 61.05m |
Free float | 53.79m |
P/E (TTM) | -- |
Market cap | 405.37m USD |
EPS (TTM) | -7.41 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 10:58 BST.
More ▼
Press releases
- Sage Therapeutics Announces Discontinuation of the Collaboration with Biogen on the SAGE-324 Program
- Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor
- Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024